GENTAMICIN SULFATE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP22F2457, issued on August 25, 2026, is a delivery order under the primary contract SPE2DX15D9383 for the procurement of Gentamicin Sulfate, identified by NSN 6505012139514. The contract was awarded to DMS Pharmaceutical Group Inc and managed by the DLA Troop Support Medical Supply Chain, adhering to standard federal acquisition regulations and defense priority clauses for commercial items. Subsequent to the initial award, modification P00001 was issued to the contract. This modification resulted in the total cancellation of CLIN 0001 for a quantity of two units at no cost to the government. This action reduced the total order amount by 55.90 dollars to a final balance of 0.00 dollars, with the cancellation attributed to aged orders and the decommissioning of ships.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
